Novartis cuts CCO title as international chief Marie-France
Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.
SEC Filing ID 0001438533-24-000005
Top 20 Pharmaceutical Companies by Revenue 2021
Novartis to cut up to 8,000 jobs globally
Global Service Providers Guide 2022 by Enhesa Product - Issuu
Novartis to cut up to 8,000 jobs globally
20-F
424B4
Marketing Awards ☆ Judges ☆
09.06.23 Novartis replaces outgoing exec, scraps CCO title; J&J's Rybrevant posts win in large lung cancer field - Questex
